Document Detail


Diatrizoate meglumine (Hypaque) treatment for sudden hearing loss.
MedLine Citation:
PMID:  459656     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During the 24 month period ending in December 1978, 31 patients with sudden idiopathic sensorineural hearing loss were treated with vasodilators and Hypaque. Fifteen patients met the treatment criteria of being treated within the first month following onset, no vertigo, and the hearing loss was not complete. Twelve patients (80%) had complete return of their hearing. Two patients (13%) had partial return of their hearing, and 1 patient (6%) had no response to treatment. Of the 16 patients treated who did not meet the criteria, 6 patients (38%) had complete return of their hearing. Eight patients (50%) had partial return of their hearing and 2 patients (12%) had no return of their hearing.
Authors:
J R Emmett; J J Shea
Related Documents :
19205166 - Vestibular findings in relapsing, remitting multiple sclerosis: a study of thirty patie...
10680926 - Dynamic asymmetry of the vestibulo-ocular reflex in unilateral peripheral vestibular an...
1527456 - Treatment of tinnitus by intratympanic instillation of lignocaine (lidocaine) 2 per cen...
18789756 - The clinical utility of posturography.
19422586 - Predictors of syncope in patients with hypertrophic cardiomyopathy.
22711896 - Coat-hanger ache in orthostatic hypotension.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Laryngoscope     Volume:  89     ISSN:  0023-852X     ISO Abbreviation:  Laryngoscope     Publication Date:  1979 Aug 
Date Detail:
Created Date:  1979-09-27     Completed Date:  1979-09-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8607378     Medline TA:  Laryngoscope     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1229-38     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Diatrizoate / analogs & derivatives*
Diatrizoate Meglumine / therapeutic use*
Female
Hearing Loss, Sensorineural / diagnosis,  drug therapy*
Hearing Loss, Sudden / diagnosis,  drug therapy*
Hearing Tests
Humans
Male
Middle Aged
Vasodilator Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 117-96-4/Diatrizoate; 131-49-7/Diatrizoate Meglumine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Amyloidosis presenting as a mass in the neck.
Next Document:  Metastatic tumors to the sphenoid sinus.